相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
Michela Piezzo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype
Francois Bertucci et al.
NPJ BREAST CANCER (2020)
Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology
Peggy M. Kostakou et al.
HEART FAILURE REVIEWS (2019)
Patterns of comorbidities in women with breast cancer: a Canadian population-based study
Huah Shin Ng et al.
CANCER CAUSES & CONTROL (2019)
Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database
Nathalie LeVasseur et al.
CLINICAL BREAST CANCER (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Oncotype DXA® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy
Alison M. Pease et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Ten-year recurrence rates for breast cancer subtypes in the Netherlands: A large population-based study
Marissa C. van Maaren et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The NeST (neoadjuvant systemic therapy in breast cancer) study - Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer
G. W. Irwin et al.
INTERNATIONAL JOURNAL OF SURGERY PROTOCOLS (2019)
Patterns of breast cancer relapse in accordance to biological subtype
Atanas Ignatov et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
Marco Colleoni et al.
LANCET ONCOLOGY (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Jose Baselga et al.
LANCET ONCOLOGY (2017)
Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case series
Asmerom Tesfamariam Sengal et al.
BMC CANCER (2017)
New methods for estimating follow-up rates in cohort studies
Xiaonan Xue et al.
BMC MEDICAL RESEARCH METHODOLOGY (2017)
Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database
Hai-long Chen et al.
PLOS ONE (2016)
Pathology of Perineural Spread
Ian S. Brown
JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE (2016)
Expression of cluster of differentiation 34 and vascular endothelial growth factor in breast cancer, and their prognostic significance
Zhanhong Chen et al.
ONCOLOGY LETTERS (2015)
Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy
Sheng Chen et al.
ONCOTARGET (2015)
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence
Daniele Santini et al.
BREAST CANCER RESEARCH (2015)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
E. C. Inwald et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
St. Gallen 2013: Brief Preliminary Summary of the Consensus Discussion
Nadia Herbeck et al.
BREAST CARE (2013)
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
Reiki Nishimura et al.
ONCOLOGY (2013)
The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells
Zhinong Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments
Yahong Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Mitch Dowsett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Issues and updates: evaluating estrogen receptor-α, progesterone receptor, and HER2 in breast cancer
D. Craig Allred
MODERN PATHOLOGY (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF ONCOLOGY PRACTICE (2010)
Metastatic Breast Cancer: Therapeutic Options According to Molecular Subtypes and Prior Adjuvant Therapy
Valentina Guarneri et al.
ONCOLOGIST (2009)
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy
Paul L. Nguyen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group
Marianne Kyndi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Histopathologic variables predict Oncotype DX™ Recurrence Score
Melina B. Flanagan et al.
MODERN PATHOLOGY (2008)
Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index:: reproducibility of grade and advantages of proliferation index
JS Meyer et al.
MODERN PATHOLOGY (2005)
Neoadjuvant chemotherapy in breast cancer
H Charfare et al.
BRITISH JOURNAL OF SURGERY (2005)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
G Arpino et al.
BREAST CANCER RESEARCH (2004)
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
B Fisher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors
HJ Kahn et al.
LABORATORY INVESTIGATION (2002)
Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution
G D'Eredita et al.
EUROPEAN JOURNAL OF CANCER (2001)
Tumor characteristics and clinical outcome of elderly women with breast cancer
SG Diab et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Liver metastases from breast cancer: Long-term survival after curative resection
M Selzner et al.
SURGERY (2000)
分享论文
